11.07.07 Stockholm – Swedish officials have allowed three families to go ahead with genetic testing and genetic selection of embryos created by in-vitro-fertilisation. One of these cases is that of Felix Richardson, a four-year-old child...
more
09.07.07 Copenhagen – Over the first months in 2007, there has been fresh momentum in the Nordic biotech investment scene. In particular, Denmark continues to attract large biotech investments and in Sweden and Finland the situation is...
more
17.05.07 Stockholm – Biovitrum AB has initiated a Phase II study for its adenosine receptor 2A agonist for treatment of neuropathic pain. The study will include up to 300 patients and results are expected in 2008. The substance is...
more
16.05.07 Resistentia Pharmaceuticals AB (Uppsala, Sweden) has initiated a Phase II dose-escalation study of its anti-IgE immunotherapy, RP01, as a treatment for allergic asthma in mid-April. RP01 induced significant production of...
more
16.03.07 Oslo – The Norvegian radioactive therapies specialist Algeta ASA will list on the Oslo Stock Exchange on 7 March. The company is doing this step to accelerate clinical development of its alpha particle nucleotide treatments for...
more
